-+ 0.00%
-+ 0.00%
-+ 0.00%
Xenon CMO Christopher John Kenney reports disposal of common shares worth $425,469.33
Share
Listen to the news
Xenon CMO Christopher John Kenney reports disposal of common shares worth $425,469.33
  • Xenon Pharmaceuticals Chief Medical Officer Christopher John Kenney sold 7,068 common shares on Aug. 28, 2026.
  • Shares sold at weighted-average prices of $60.17, $60.98.
  • Kenney’s direct holding fell to 2 common shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xenon Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-377309), on August 31, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending